Natera Inc 's Revenue in the fiscal year 2025 $ 2,306.11 millions
Natera Inc 's Revenue in the fiscal year 2024 $ 1,696.91 millions
Natera Inc 's Revenue in the fiscal year 2023 $ 1,082.57 millions
Natera Inc 's Revenue in the fiscal year 2022 $ 820.22 millions
Natera Inc 's Revenue in the fiscal year 2021 $ 625.49 millions
NTRA Revenue second quarter 2026 Y/Y Growth Comment
Natera Inc achieved in the second quarter 2026, above Company average Revenue growth of 37.71% year on year, to $ 752.75 millions.
Looking into second quarter 2026 results within Medical Laboratories industry 7 other companies have achieved higher Revenue growth. While Natera Inc ' s Revenue rise of 37.71% ranks overall at the positon no. 602 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Natera Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
35.54 %
7.45 %
-16.02 %
(Mar 31 2021)
NTRA's II. Quarter Q/Q Revenue Comment
Natera Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 8.05%, to $ 752.75 millions, from $696.64 millions in the first quarter.
Within Medical Laboratories industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Natera Inc 's Revenue growth quarter on quarter, overall rank is 896.
Natera Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 8.05%, to $ 752.75 millions, from $696.64 millions in the first quarter.
Within Medical Laboratories industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Natera Inc 's Revenue growth quarter on quarter, overall rank is 896.
Natera Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 2,707.08
$ 2,500.93
$ 2,306.11
$ 2,116.67
$ 1,964.25
Y / Y Revenue Growth (TTM)
37.82 %
36.59 %
35.9 %
38.17 %
44.38 %
Year on Year Revenue Growth Overall
Ranking
# 295
# 116
# 114
# 210
# 119
Seqeuential Revenue Change (TTM)
8.24 %
8.45 %
8.95 %
7.76 %
7.28 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1612
# 1136
# 806
# 1000
# 923
Cumulative Revenue growth Comment
Although Natera Inc 's Annual Revenue growth year on year were below company's average 55.32% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 37.82% year on year, from 36.59% in Mar 31 2026.
In the Healthcare sector 84 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 116 to 295.
Although Natera Inc 's Annual Revenue growth year on year were below company's average 55.32% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 37.82% year on year, from 36.59% in Mar 31 2026.
In the Healthcare sector 84 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 116 to 295.
About Natera Inc Revenue Growth Rates (NTRA), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
65.69%